Michaela Levin insider trades

Open-market stock purchases and sales by Michaela Levin, Chief Business Officer at Acrivon Therapeutics, Inc, from SEC Form 4 filings since Aug 31, 2026.

Recent trades

DateStockTradeValue
Aug 31, 2026ACRV Acrivon Therapeutics, IncBought (not open market)—
Aug 31, 2026ACRV Acrivon Therapeutics, IncBought (not open market)—

Companies traded

  • ACRV Acrivon Therapeutics, Inc: other filings, last Aug 31, 2026

Get free alerts when Michaela Levin files a new trade →